ã¬ãŒãããŒ2026幎第3ååææ±ºç®ïŒGAAPããŒã¹ã§ã®æžå°ã«ãããããã調æŽåŸå£²äžé«ã¯å¢å
ã¬ãŒãããŒã®2026幎第3ååææ±ºç®ã¯ãäºæ¥å£²åŽã«äŒŽãå ±åããŒã¹ã®æžåãå幎åæã®æžææå€±ã®ååã«ããçŽå©çã®æ¥å¢ã衚é¢äžã®æ°å€ãæªããŠããŸããå®è³ªçãªç¶ç¶äºæ¥ã¯å 調ã§ã調æŽåŸå£²äžé«ã調æŽåŸEPSã¯å¢å ããŸããã3ã»ã°ã¡ã³ããã¹ãŠã§å¢åãéæããå¥çŽäŸ¡å€ããã©ã¹æé·ã瀺ããŠããŸããäžæ¹ãã€ã³ãµã€ãéšéã®ç·©ãããªæé·ããèšåæè³æå¶ã«äŸåããããªãŒãã£ãã·ã¥ãããŒã®å¢å ãèªç€Ÿæ ªè²·ãã«ããEPSæé·ã®åºäžãããªã¹ã¯èŠå ãšããŠæããããŸããä»åŸã®æ³šç®ç¹ã¯å¥çŽäŸ¡å€ã®å£²äžè»¢æãå¶æ¥ãã£ãã·ã¥åµåºã®æ¹åååã§ãã
ã¬ãŒãããŒïŒNYSE: ITïŒãçºè¡šãã2026幎9æ30æ¥ãæ«æ¥ãšãã第3ååææ±ºç®ã¯ã売äžé«ãå幎åæã®15å2,400äžãã«ãã1.3%æžã®15å500äžãã«ãšãªã£ãäžæ¹ãåžèååŸEPSã¯0.47ãã«ãã3.35ãã«ã«äžæããŸããã調æŽåŸå£²äžé«ã¯2.4%å¢å ã売åŽäºæ¥ãé€ã調æŽåŸEBITDAã¯7.5%å¢å ãããªãŒãã£ãã·ã¥ãããŒã¯2.2%å¢å ããŸãããGAAP売äžé«ãšèª¿æŽåŸæ¥çžŸã®ä¹é¢ã¯äž»ã«ããžã¿ã«ã»ããŒã±ããäºæ¥ã®å£²åŽãåæ ãããã®ã§ãããGAAPçŽå©çã®å€§å¹ å¢ã¯å幎åæã«èšäžãããæžææå€±ããã³äºæ¥åç·šè²»çšã®ååã«ãã圱é¿ã倧ãããªã£ãŠããŸãã
äž»èŠæ¥çžŸãã€ã©ã€ã
ã¬ãŒãããŒã®å£²äžé«ïŒå ±åããŒã¹ïŒãæžå°ããã®ã¯ãå幎åæã«å£²åŽæžã¿ã®ããžã¿ã«ã»ããŒã±ããäºæ¥ã«ãã売äžé«5,500äžãã«ãå«ãŸããŠããããã§ããåäºæ¥ãé€ã調æŽåŸå£²äžé«ã¯14å6,900äžãã«ãã15å500äžãã«ã«å¢å ããå ±åããŒã¹ã§2.4%å¢ãçºæ¿åœ±é¿ãé€ãããŒã¹ã§2.6%å¢ãšãªããŸããã
åçã®åºèª¿ã¯æ¹åãããã®ã®ãGAAPããŒã¹ã®åå¹Žåææ¯èŒã¯å幎åæã®è²»çšèšäžã«å€§ãã圱é¿ãåããŸããã調æŽåŸEPSã¯30.1%å¢å ãã売åŽäºæ¥ãé€ã調æŽåŸEBITDAã¯7.5%å¢å ããŸããã
| ææš | 2026幎第3ååæ | 2025幎第3ååæ | åå¹Žåææ¯ |
|---|---|---|---|
| GAAP売äžé« | 15å500äžãã« | 15å2,400äžãã« | -1.3% |
| 調æŽåŸå£²äžé« | 15å500äžãã« | 14å6,900äžãã« | +2.4% |
| GAAPçŽå©ç | 2å1,440äžãã« | 3,540äžãã« | +506.4% |
| åžèååŸEPS | 3.35ãã« | 0.47ãã« | +612.8% |
| 売åŽäºæ¥ãé€ã調æŽåŸEBITDA | 3å6,400äžãã« | 3å3,900äžãã« | +7.5% |
| 調æŽåŸEPS | 3.59ãã« | 2.76ãã« | +30.1% |
| å¶æ¥ãã£ãã·ã¥ãã㌠| 2å9,400äžãã« | 2å9,900äžãã« | -1.4% |
| ããªãŒãã£ãã·ã¥ãã㌠| 2å7,500äžãã« | 2å6,900äžãã« | +2.2% |
äºæ¥ã»ã»ã°ã¡ã³ã奿¥çžŸ
3ã€ã®äºæ¥ã»ã°ã¡ã³ããã¹ãŠã§å¢åãéæãããã®ã®ãæé·çããã³è²¢ç®å©çã®ååã«ã¯éããèŠãããŸããã
- ã€ã³ãµã€ãéšéïŒå£²äžé«ã¯1.7%å¢ã®12å9,200äžãã«ïŒçºæ¿åœ±é¿ãé€ãããŒã¹ã§1.8%å¢ïŒãšãªããŸãããç²è²¢ç®å©çã¯2.9%å¢ã®10å300äžãã«ãšãªããè²¢ç®å©ççã¯77.6%ã«éããŸãããã¬ãŒãããŒæå€§èŠæš¡ã®ã»ã°ã¡ã³ãã§ããããããã®ç·©ãããªæé·ãå šäœæé·ã®äž»ãªæå¶èŠå ã«ãšã©ãŸããŸããã
- ã«ã³ãã¡ã¬ã³ã¹éšéïŒå£²äžé«ã¯3ã»ã°ã¡ã³ãäžæãé«ã15.4%å¢ã®8,600äžãã«ã«æ¥å¢ããŸãããç²è²¢ç®å©çã¯å¢åçãäžåã9.8%å¢ã®3,000äžãã«ãšãªããè²¢ç®å©ççã¯34.9%ã§ããã
- ã³ã³ãµã«ãã£ã³ã°éšéïŒå£²äžé«ã¯2.3%å¢ã®1å2,640äžãã«ïŒçºæ¿åœ±é¿ãé€ãããŒã¹ã§3.0%å¢ïŒãšãªããŸãããç²è²¢ç®å©çã¯å šã»ã°ã¡ã³ãã§æé«ãšãªã21.3%å¢ã®4,300äžãã«ã«äŒžã³ãè²¢ç®å©ççã¯33.8%ãšãªããŸããã
çºæ¿åœ±é¿ãé€ãå¥çŽäŸ¡å€ïŒCVïŒã¯53åãã«ã«éããåå¹Žåææ¯2.5%å¢ãåååææ¯1.1%å¢ãšãªããŸãããã°ããŒãã«ã»ãã¯ãããžãŒã»ã»ãŒã«ã¹ã®å¥çŽäŸ¡å€ã¯åå¹Žåææ¯2.1%å¢ã®40åãã«ãã°ããŒãã«ã»ããžãã¹ã»ã»ãŒã«ã¹ã¯ãããäžåãå3.7%å¢ã®13åãã«ã«æ¡å€§ããŸããã
äºæ¥å£²åŽãšå幎åæã®æžææå€±ã衚é¢äžã®æé·çãæªæ²
GAAPããŒã¹ã®1.3%æžåãšèª¿æŽåŸããŒã¹ã®2.4%å¢åã¯ãæ¯èŒåºæºã®éãã«ãããã®ã§ãã2025幎第3ååæã«ã¯ãã¬ãŒãããŒã2026幎2æã«å£²åŽããããžã¿ã«ã»ããŒã±ããäºæ¥ããã®å£²äžé«5,500äžãã«ãå«ãŸããŠããŸãããåäºæ¥ã®åœ±é¿ãé€å€ãããšãå幎åæã®å£²äžé«ããŒã¹ã¯14å6,900äžãã«ãžãšäžãããç¶ç¶äºæ¥ã®å®è³ªçãªæé·ã確èªã§ããŸãã
GAAPçŽå©çã®æ¥å¢ã¯ãå幎åæã®ç¹æ®èŠå ã«ããã«å€§ãã圱é¿ãããŠããŸãã2025幎第3ååæã«ã¯ãããžã¿ã«ã»ããŒã±ããäºæ¥ã®ã®ããæžææå€±1å5,000äžãã«ãå«ã1å5,400äžãã«ã®ã®ããããã³ãã®ä»è³ç£ã®æžææå€±ã«å ãã人å¡åæžè²»çã®éçµåžžè²»çš2,500äžãã«ãèšäžãããŠããŸãããããã«å¯Ÿãã2026幎åæã«ã¯æžææå€±ã®èšäžã¯ãªãã人å¡åæžè²»çã®éçµåžžè²»çšã100äžãã«ã«ãšã©ãŸããŸããã
ãããã£ãŠã調æŽåŸææšã®æ¹ãäºæ¥ã®å®æ ãããæ£ç¢ºã«ç€ºããŠããŸãã売åŽäºæ¥ãé€ã調æŽåŸEBITDAã¯7.5%å¢å ãã調æŽåŸEPSã¯30.1%å¢å ããŸããããŸããEPSã®äžæã¯ãåžèååŸæ ªåŒæ°ã7,500äžæ ªãã6,390äžæ ªãžãšçŽ14.8%æžå°ããããšã«ããæ©æµãåããŠããŸãã
åçæ§ãšãã£ãã·ã¥ãããŒ
売åŽäºæ¥ãé€ã調æŽåŸEBITDAããŒãžã³ã¯å幎åæã®çŽ23.1%ããçŽ24.2%ãžãšçŽ1.1ãã€ã³ãæ¡å€§ããŸãããããã¯ã調æŽåŸå©çãæ¯èŒå¯Ÿè±¡ã®å£²äžé«ããŒã¹ãããéãããŒã¹ã§æé·ããããšãæå³ããŠããŸãã
å¶æ¥ãã£ãã·ã¥ãããŒã¯500äžãã«æžå°ããŠ2å9,400äžãã«ãšãªããŸãããèšåæè³é¡ã2,900äžãã«ãã1,900äžãã«ãžãšæžå°ãããããå¶æ¥ãã£ãã·ã¥ãããŒã®æžå°ã«ãããããããããªãŒãã£ãã·ã¥ãããŒã¯600äžãã«å¢ã®2å7,500äžãã«ã«æ¡å€§ããŸããããããã£ãŠãåœååæã®ããªãŒãã£ãã·ã¥ãããŒã®æ¹åã¯ãå¶æ¥ãã£ãã·ã¥åµåºåã®åŒ·åã«ãããã®ã§ã¯ãªããèšåæè³ã®æå¶ã«ãããã®ã§ãã
åœååæäžã«ã¬ãŒãããŒã¯1å3,800äžãã«ã§90äžæ ªã®èªç€Ÿæ ªè²·ãã宿œããŸãããçµå¶é£ã¯éå»4ååæã§èš17åãã«ã®èªç€Ÿæ ªè²·ããè¡ã£ãããšãå ±åããŠããããããåžèååŸæ ªåŒæ°ã®æžå°ã«å¯äžããŸãããããã®èªç€Ÿæ ªè²·ããæ ªäŸ¡ããªã¥ãšãŒã·ã§ã³ã«é¢ããã·ã°ãã«ãšã¯äœçœ®ä»ããŠããŸããã
çŽè¿ã®ã€ã³ãµã€ããŒååŒ
éå»6ã¶æéã®ã€ã³ãµã€ããŒååŒããŒã¿ã§ã¯ãè³Œå ¥ååŒã13ä»¶ïŒèš8,135æ ªïŒã売åŽååŒã5ä»¶ïŒèš7,082æ ªïŒãšãªããçŽè²·ä»é«ã¯1,053æ ªã§ãããéå»2幎éã®ååŒã¬ããŒãã«ãããææ°10ä»¶ã®èšé²ã®ãã¡ã5ä»¶ã売åŽãšããŠæç€ºãããŠããŸããååŒçš®å¥ãéé¡ãé瀺ãããŠããªãèšé²ã¯ä»¥äžããé€å€ããŠããŸãã
| æ¥ä» | ã€ã³ãµã€ããŒïŒé¢ä¿è ïŒ | åœ¹è· | ååŒçš®å¥ | 1æ ªãããäŸ¡æ Œ | å ±åéé¡ |
|---|---|---|---|---|---|
| 2026幎8æ27æ¥ | Robin B. Kranich | å·è¡åœ¹å¡ | å£²åŽ | 196.50ãã« | 644,127ãã« |
| 2026幎8æ24æ¥ | Akhil Jain | å·è¡åœ¹å¡ | å£²åŽ | 201.73ãã« | 141,211ãã« |
| 2026幎8æ10æ¥ | Yvonne Genovese | å·è¡åœ¹å¡ | å£²åŽ | 190.06ãã« | 229,022ãã« |
| 2026幎8æ7æ¥ | Anne Sutherland Fuchs | åç· åœ¹ | å£²åŽ | 184.30ãã« | 158,500ãã« |
| 2026幎8æ7æ¥ | Claire L. Herkes | å·è¡åœ¹å¡ | å£²åŽ | 190.71ãã« | 198,148ãã« |
ãããé瀺ããã5ä»¶ã®å£²åŽååŒã®åèšå ±åéé¡ã¯1,371,008ãã«ã§ããããªããååŒããŒã¿ã®ã¿ããã€ã³ãµã€ããŒã®ã¬ãŒãããŒã®èŠéãã«å¯ŸããèŠè§£ã確å®ããããšã¯ã§ããŸããã
æè³å®¶ã泚èŠãã¹ããªã¹ã¯
- æå€§èŠæš¡ã®äºæ¥ã«ãããç·©ãããªæé·ïŒã€ã³ãµã€ãéšéã®å£²äžé«ã¯1.7%å¢ã«ãšã©ãŸããçºæ¿åœ±é¿ãé€ãã°ããŒãã«ã»ãã¯ãããžãŒã»ã»ãŒã«ã¹ã®å¥çŽäŸ¡å€ã¯2.1%å¢ã«ãšã©ãŸããŸãããé£çµããŒã¹ã§ã®æé·å éã¯ããããå€§èŠæš¡äºæ¥ã®æ¹åã«å€§ããäŸåããããšã«ãªããŸãã
- ã«ã³ãã¡ã¬ã³ã¹éšéã®è²¢ç®å©çã®äŒžã³ã売äžå¢ãäžåãïŒã«ã³ãã¡ã¬ã³ã¹éšéã®å£²äžé«ã¯15.4%å¢å ãããã®ã®ãç²è²¢ç®å©çã¯9.8%å¢ã«ãšã©ãŸããŸããããã®ä¹é¢ãç¶ç¶ããå Žåãåã»ã°ã¡ã³ãã®æ¥éãªå¢åãããã«æ¯äŸããå©çæé·ã«ã€ãªãããªãå¯èœæ§ããããŸãã
- ããªãŒãã£ãã·ã¥ãããŒã®å¢å ã¯èšåæè³ã®æå¶ã«äŸåïŒå¶æ¥ãã£ãã·ã¥ãããŒãæžå°ããäžãããªãŒãã£ãã·ã¥ãããŒã®å¢å ã¯1,000äžãã«ã®èšåæè³åæžã«ãã£ãŠæ¯ããããŸãããå¶æ¥ãã£ãã·ã¥åµåºã®æ¹åã䌎ããã«èšåæè³ãå¢å ããå ŽåãããªãŒãã£ãã·ã¥ãããŒã®äŒžã³ãéåãããããããããŸãã
- èªç€Ÿæ ªè²·ããEPSæé·ãåºäžãïŒåžèååŸæ ªåŒæ°ãçŽ14.8%æžå°ããããšã§ã調æŽåŸEPSã®äŒžã³ã¯èª¿æŽåŸEBITDAã®äŒžã³ã倧ããäžåããŸãããä»åŸèªç€Ÿæ ªè²·ãã®ããŒã¹ãå€åããã°ã1æ ªåœããå©çã®æé·çã¯æ¬æ¥ã®å©çæé·ã«ããé£åããããã«ãªãå¯èœæ§ããããŸãã
ãŸãšã
ã¬ãŒãããŒã®2026幎第3ååææ±ºç®ã¯ãç¶ç¶äºæ¥ã«ãããç·©ãããªæé·ã調æŽåŸåçæ§ã®æ¹åãããã³äž¡è²©å£²ã«ããŽãªãŒã«ãããå¥çŽäŸ¡å€ã®ãã©ã¹æé·ã瀺ããŸãããå ±åããŒã¹ã®æžåã¯ããžã¿ã«ã»ããŒã±ããäºæ¥ã®å£²åŽãåæ ãããã®ã§ãããGAAPçŽå©çã®ç°äŸã®å€§å¹ å¢ã¯ãå幎åæã«èšäžãããæžææå€±ããã³äºæ¥åç·šè²»çšã®ååãæ ªåŒæ°ã®æžå°ãäžå ãšãªã£ãŠããŸããä»åŸã®äž»ãªæ³šèŠç¹ã¯ãå¥çŽäŸ¡å€ã®å£²äžãžã®è»¢æç¶æ³ãã€ã³ãµã€ãéšéã®æé·ãã«ã³ãã¡ã¬ã³ã¹éšéã®è²¢ç®å©çã®ååããããŠèšåæè³ã®åæžã«é Œããå¶æ¥ãã£ãã·ã¥ãããŒãæ¹åã§ãããã©ããã§ãã
ãã®èšäºã®äžéšã¯AIã«ãã£ãŠçæã»ç¿»èš³ããã人éã«ããã¬ãã¥ãŒãçµãŠããŸããããã¯äžè¬çãªæ å ±æäŸã®ç®çã§ã®ã¿äœ¿çšãããŠãããæè³ã¢ããã€ã¹ãæ§æãããã®ã§ã¯ãããŸããã
ããããèšäº











ã³ã¡ã³ã (0)
$ãã¿ã³ãã¯ãªãã¯ããã·ã³ãã«ãå ¥åããŠãæ ªåŒãETFããŸãã¯ãã®ä»ã®ãã£ãã«ãŒã·ã³ãã«ããªã³ã¯ããŸãã